Emerging research suggests that addressing inflammation, promoting cellular repair, and balancing hormone production could provide a more comprehensive approach to managing depression
Several tripeptides have been extensively studied for their roles in modulating wound healing pathways, offering concrete evidence of their efficacy in both preclinical and clinical contexts
The Shaking Catastrophe: We've already mentioned this, but it bears repeating
It bypasses first-pass hepatic metabolism which oral delivery does not allowing a greater proportion of the absorbed peptide to remain intact as it enters circulation.7 The olfactory pathway also provides a potential direct nose-to-brain route, bypassing the blood-brain barrier a property that has generated interest for neuropeptides and potential neurological applications
Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
